CD4 and lung cancer: In previous studies on patients with malignant neoplasms such as lung cancer, esophageal cancer, colorectal cancer, and gastric cancer, researchers have detected decreased levels of CD3 + T cells, CD4 + T cells , NK cells, and CD4 + /CD8 + ratio in peripheral blood4,57–60.